Quantum News
Sign InSign Up
Back to News
research

Friday 4/10 Insider Buying Report: CNXC, ALT

BNK Invest
Loading...
2 min read
0 likes
⚡ Quantum Brief
Two corporate insiders made significant stock purchases this week, signaling potential confidence in their companies’ futures. Concentrix Corp’s CFO bought $69,869 worth of shares, while Altimmune saw a director acquire $31,350 in stock. Concentrix Corp’s CFO, Andre Valentine, purchased 2,500 shares at $27.95 each on Thursday. The stock briefly surged 7.1% to $29.94 Friday before closing nearly 1% lower, reflecting volatile but optimistic trading. Altimmune’s director, John Gill, bought 9,200 shares at $3.41 each Monday, totaling $31,350. This follows a prior $51,250 purchase last year at $4.10 per share, suggesting long-term bullishness despite Friday’s 4.2% decline. Insider buys often indicate executive confidence in undervalued stocks. Both transactions precede broader market movements, with Concentrix outperforming Altimmune in short-term gains but both facing intraday volatility. The report highlights insider activity as a key market indicator, emphasizing that while sales have varied motives, purchases typically reflect expectations of future profitability and growth.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (30).png
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets CNXC Friday 4/10 Insider Buying Report: CNXC, ALT April 10, 2026 — 01:39 pm EDT Written by BNK Invest for BNK Invest-> As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Thursday, Concentrix Corp (CNXC)'s Chief Financial Officer, Andre S. Valentine, made a $69,869 buy of CNXC, purchasing 2,500 shares at a cost of $27.95 each. Valentine was up about 7.1% on the buy at the high point of today's trading session, with CNXC trading as high as $29.94 at last check today. Concentrix Corp is trading off about 1% on the day Friday. And at Altimmune (ALT), there was insider buying on Monday, by John Gill who purchased 9,200 shares for a cost of $3.41 each, for a trade totaling $31,350. Before this latest buy, Gill made one other buy in the past year, purchasing $51,250 shares for a cost of $4.10 a piece. Altimmune is trading down about 4.2% on the day Friday. VIDEO: Friday 4/10 Insider Buying Report: CNXC, ALT The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocks BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally. 10 Bargains You Can Buy Cheaper Than Insiders Did-> 10 Stocks Crossing Below Book Value-> 10 Oversold Stocks You Need To Know About-> More articles by this source-> Stocks mentioned CNXC ALT More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Source: Nasdaq

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.